110 related articles for article (PubMed ID: 3009188)
1. Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29).
Luis J; Muller JM; Abadie B; Martin JM; Marvaldi J; Pichon J
Eur J Biochem; 1986 May; 156(3):631-6. PubMed ID: 3009188
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
3. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
Muller JM; Luis J; Fantini J; Abadie B; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1985 Sep; 151(2):411-7. PubMed ID: 2992966
[TBL] [Abstract][Full Text] [Related]
4. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the vasoactive intestinal peptide (VIP) binding sites: a biochemical and an immunological approach.
Marvaldi J; Luis J; Muller JM; el Battari A; Fantini J; Martin JM; Abadie B; Tirard A; Pichon J
Peptides; 1986; 7 Suppl 1():137-45. PubMed ID: 3018691
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
Broyart JP; Dupont C; Laburthe M; Rosselin G
J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
[TBL] [Abstract][Full Text] [Related]
8. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409
[TBL] [Abstract][Full Text] [Related]
9. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
[TBL] [Abstract][Full Text] [Related]
11. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
[TBL] [Abstract][Full Text] [Related]
12. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line.
Omary MB; Kagnoff MF
Science; 1987 Dec; 238(4833):1578-81. PubMed ID: 2825352
[TBL] [Abstract][Full Text] [Related]
13. Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29).
Muller JM; el Battari A; Ah-Kye E; Luis J; Ducret F; Pichon J; Marvaldi J
Eur J Biochem; 1985 Oct; 152(1):107-14. PubMed ID: 4043073
[TBL] [Abstract][Full Text] [Related]
14. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
[TBL] [Abstract][Full Text] [Related]
15. Receptors for vasoactive intestinal peptide on isolated epithelial cells of rat ventral prostate.
Prieto JC; Carmena MJ
Biochim Biophys Acta; 1983 Dec; 763(4):408-13. PubMed ID: 6317051
[TBL] [Abstract][Full Text] [Related]
16. [Desensitization to VIP by down regulation of its peptide receptors in transformed HT-29 cells of human colonic epithelium in culture].
Boissard C; Hejblum G; Marie JC; Gespach C; Rosselin G
C R Acad Sci III; 1984; 299(19):795-8. PubMed ID: 6099208
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
Inoue Y; Kaku K; Kaneko T; Yanaihara N; Kanno T
Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
[TBL] [Abstract][Full Text] [Related]
18. Cycle of VIP in the human transformed colonic epithelial cells (HT-29) in culture.
Marie JC; Hui Bon Hoa D; Hejblum G; Rosselin G
Peptides; 1986; 7 Suppl 1():129-35. PubMed ID: 3748845
[TBL] [Abstract][Full Text] [Related]
19. Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells.
Hohmann EL; Tashjian AH
Endocrinology; 1984 Apr; 114(4):1321-7. PubMed ID: 6323142
[TBL] [Abstract][Full Text] [Related]
20. Combined ultrastructural and biochemical study of cellular processing of vasoactive intestinal peptide and its receptors in human colonic carcinoma cells in culture.
Hejblum G; Gali P; Boissard C; Astesano A; Marie JC; Anteunis A; Hui Bon Hoa D; Rosselin G
Cancer Res; 1988 Nov; 48(21):6201-10. PubMed ID: 2844402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
